The fact that? The United Kingdom Advertising Standards Authority (ASA) investigated three issues related to a list of Roche-Posay products after a Beeriersdorf UK LTD challenge, defending one and rejecting two.
The details The case referred to an announcement of the December site 2024 for the MELA B3 cleaner of the Roche-Posay. Beiersdorf UK LTD challenged Wheter’s claims, including “a new mode of action as never before” and “dermatologist No.1 Edommende Brand in the United Kingdom” were misleading and capable of justifying. The ASA discovered that the claim of the “new mode of action” was backed by evidence that showed that active mellyl worked differently to existing hyperpigmentation treatments, and accepted the justification of the claim “No.1” based on surveys of dermatologists in the United Kingdom. However, the regulator confirmed a complaint about verifiability, ruling that the announcement could not sign clearly where consumers could verify the basic claim of “No.1”. The announcement should not appear again in its current form, and future communications must be clearer for comparative claims.
Why? The ruling emphasizes that beauty advertisers should not only corroborate comparative claims, but also ensure that they are easily verifiable to avoid violating the advertising codes of the United Kingdom.
Fountain: Handle
